NCT/Study#
NCT05776134 /
KT-US-472-0141
Expanded Access Study for the Treatment of Patients with Commercially Out-of-Specification Brexucabtagene Autoleucel
DISEASE GROUP:
Bone Marrow Transplant
current phase:
N/A
STUDY STATUS:
Enrolling
Location:
Hackensack, NJ
For More information:
